Moreno Evelyn V Sells 550 Shares of Danaher Corporation (DHR)
Moreno Evelyn V decreased its position in Danaher Corporation (NYSE:DHR) by 0.8% during the second quarter, Holdings Channel reports. The firm owned 72,555 shares of the conglomerate’s stock after selling 550 shares during the period. Danaher Corporation accounts for about 1.9% of Moreno Evelyn V’s investment portfolio, making the stock its 27th largest position. Moreno Evelyn V’s holdings in Danaher Corporation were worth $6,123,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of DHR. Bank of Montreal Can raised its position in Danaher Corporation by 13.7% in the first quarter. Bank of Montreal Can now owns 559,878 shares of the conglomerate’s stock valued at $47,887,000 after buying an additional 67,349 shares during the last quarter. Regentatlantic Capital LLC raised its position in Danaher Corporation by 28.9% in the first quarter. Regentatlantic Capital LLC now owns 51,036 shares of the conglomerate’s stock valued at $4,365,000 after buying an additional 11,454 shares during the last quarter. CrestPoint Capital Management LLC raised its position in Danaher Corporation by 16.7% in the first quarter. CrestPoint Capital Management LLC now owns 7,700 shares of the conglomerate’s stock valued at $659,000 after buying an additional 1,100 shares during the last quarter. TNB Financial purchased a new position in Danaher Corporation during the first quarter valued at about $477,000. Finally, Private Trust Co. NA raised its position in Danaher Corporation by 0.3% in the first quarter. Private Trust Co. NA now owns 19,081 shares of the conglomerate’s stock valued at $1,632,000 after buying an additional 49 shares during the last quarter. Institutional investors own 76.56% of the company’s stock.
Shares of Danaher Corporation (NYSE DHR) traded up 0.82% during trading on Friday, hitting $79.94. 1,225,874 shares of the stock traded hands. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The company has a 50 day moving average price of $83.07 and a 200 day moving average price of $84.21. The firm has a market cap of $55.53 billion, a price-to-earnings ratio of 25.52 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period last year, the company posted $0.90 EPS. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. Analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/moreno-evelyn-v-sells-550-shares-of-danaher-corporation-dhr.html.
Several equities analysts recently issued reports on DHR shares. Zacks Investment Research lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Deutsche Bank AG restated a “buy” rating and issued a $97.00 target price on shares of Danaher Corporation in a report on Wednesday, June 21st. BTIG Research restated a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a report on Sunday, April 23rd. Vetr upgraded shares of Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 target price on the stock in a report on Thursday, April 20th. Finally, Wells Fargo & Company started coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Danaher Corporation currently has an average rating of “Buy” and a consensus target price of $91.76.
In related news, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 38,623 shares of company stock valued at $3,206,426. 12.20% of the stock is currently owned by corporate insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.